Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric and Gastroesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06786169
What this trial is testing

The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer

Who this might be right for
Gastric Cancer, Gastroesophageal Junction Cancer
Fudan University 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT06667050
What this trial is testing

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
West China Hospital 58
Early research (Phase 1)Study completedNCT03652077
What this trial is testing

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Who this might be right for
Cervical CancerGastric CancerStomach Cancer+18 more
Incyte Corporation 40
Testing effectiveness (Phase 2)Temporarily pausedNCT06728657
What this trial is testing

Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma

Who this might be right for
Stomach AdenocarcinomaGastro-esophageal Junction Cancer
Fudan University 68
Testing effectiveness (Phase 2)UnknownNCT06222944
What this trial is testing

Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA

Who this might be right for
Gastric CancerAdenocarcinoma of Esophagogastric Junction
Peking University 90
Testing effectiveness (Phase 2)Looking for participantsNCT06219941
What this trial is testing

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction CancerBiliary Tract Cancer+1 more
AstraZeneca 226
Testing effectiveness (Phase 2)Active Not RecruitingNCT06921928
What this trial is testing

Study for AZD4360 in Participants With Advanced Solid Tumours

Who this might be right for
Gastric CancerGastroesophageal Junction CancerBiliary Tract Cancer+1 more
AstraZeneca 31
Testing effectiveness (Phase 2)Looking for participantsNCT04840264
What this trial is testing

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction AdenocarcinomaPeritoneal Carcinomatosis
Sixth Affiliated Hospital, Sun Yat-sen University 79
Testing effectiveness (Phase 2)Study completedNCT02891447
What this trial is testing

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaPeritoneal Carcinomatosis
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT06044961
What this trial is testing

Radiomics-based Models for the Prediction of Pathological Response to Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer

Who this might be right for
Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Testing effectiveness (Phase 2)Study completedNCT07791329
What this trial is testing

Sequential FDG-PET and miRNA as Biomarkers of Preoperative Treatment Strategy in LA Oesophago-Gastric Cancer

Who this might be right for
Adenocarcinoma - Gastroesophageal Junction (GEJ)Gastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma
Masaryk Memorial Cancer Institute 144
Testing effectiveness (Phase 2)Study completedNCT01932580
What this trial is testing

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
McGill University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817826
What this trial is testing

TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.

Who this might be right for
Gastric CancerMicrosatellite Instability
Gruppo Oncologico del Nord-Ovest 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06871527
What this trial is testing

Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

Who this might be right for
Gastric (Stomach) CancerGastric AdenocarcinomaFruquintinib+3 more
Sixth Affiliated Hospital, Sun Yat-sen University 44
Early research (Phase 1)Looking for participantsNCT05187182
What this trial is testing

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerStomach Cancer+2 more
Washington University School of Medicine 42
Not applicableLooking for participantsNCT06277024
What this trial is testing

A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients

Who this might be right for
Overall Response Rate
Fujian Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04581473
What this trial is testing

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

Who this might be right for
Gastric AdenocarcinomaPancreatic CancerGastroesophageal Junction Adenocarcinoma
CARsgen Therapeutics Co., Ltd. 192
Large-scale testing (Phase 3)Ended earlyNCT03019588
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063)

Who this might be right for
Gastric NeoplasmsGastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLC 94
Large-scale testing (Phase 3)Looking for participantsNCT06028737
What this trial is testing

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerStomach CancerGastroEsophageal Cancer+13 more
Ukrainian Society of Clinical Oncology 150
Early research (Phase 1)Ended earlyNCT03735290
What this trial is testing

Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more
Mendus 21
Next Page